{"id":263823,"date":"2026-09-23T11:33:59","date_gmt":"2026-09-23T06:03:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=263823"},"modified":"2026-09-23T11:33:59","modified_gmt":"2026-09-23T06:03:59","slug":"piramal-pharma-stock-signals-investors-are-watching","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/piramal-pharma-stock-signals-investors-are-watching\/","title":{"rendered":"Piramal Pharma: 7 Stock Signals Investors Are Watching Right Now"},"content":{"rendered":"

Piramal Pharma CMP Rs 210.90. 52W range Rs 132.30-231.93. Mcap Rs 27,978 crore. PE NA vs sector 38.56.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Piramal Pharma stock signals right now span an earnings picture, a shareholding pattern where promoter holding promoter and institutional shareholding figures were not available from the data source used here; investors can check the company’s latest exchange filing directly, and a technical setup where the stock trades well off its 52-week low of Rs 132.30. Debt to equity stands at 0.7, and valuation sits at a P\/E of not meaningful for this stock right now against a sector average of 38.56. Corporate developments in the contract development, manufacturing and pharmaceuticals space add further context investors are tracking alongside these numbers. None of the seven signals here amounts to a buy or sell call on its own.<\/p>\n<\/p><\/div>\n

Piramal Pharma stock signals are unusually layered right now, with the company trading at Rs 210.90, 9.1% below its 52-week high of Rs 231.93 and 59.4% above its 52-week low of Rs 132.30. Piramal Pharma is a well tracked name in the contract development, manufacturing and pharmaceuticals space, and no single headline captures where the stock stands today.<\/p>\n

This article does not make a buy, hold or sell call on Piramal Pharma. It lays out seven signals investors commonly watch, each sourced from the company’s latest exchange disclosures and financial statements, so readers can form their own view of what is currently working for the stock and what still needs to be watched.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n